About Sanjin Pharmaceutical

Guilin sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group, mainly engaged in the research and development and production of proprietary Chinese medicines and natural medicines, and is one of the earliest modern Chinese medicine preparation manufacturers in China. Since 1985, guilin sanjin has persisted in reform and innovation, relying on scientific and technological progress and scientific management. The main economic indicators increase by about 30% annually. In 2009, the company achieved operating income of11.10.00 billion yuan and total profit of 377 million yuan, both of which increased by more than 10% year-on-year. It ranks among the top 50 Chinese medicine enterprises in China, and has successively won the honors of national advanced enterprise with quality and efficiency, national outstanding contribution award for enterprise management, national May 1st Labor Award, national outstanding enterprise in ideological and political work, national civilized unit and national outstanding enterprise in Chinese medicine industry. Chinese medicine is the quintessence of China. As a member of authentic Guangxi pharmaceutical companies and traditional industries, Sanjin established the research and development direction of "inheriting ancient laws and carrying forward traditions" at the beginning of its rise, adhered to the guidance of Chinese medicine theory, relied on modern science and technology, abandoned the old road of low-level imitation, independently innovated exclusive products and built its own well-known brands. At present, Sanjin has become a well-known high-tech enterprise in and outside the region, with complete innovation system, sufficient R&D investment and strong R&D strength. It has a national technology center and a postdoctoral research center. The company's existing new Chinese medicine is basically developed by the enterprise technology center, with independent intellectual property rights and more than 20 national Chinese medicine invention patents or national Chinese medicine protected varieties. At present, Sanjin has formed a strong professional and market advantage in the fields of throat, oral cavity and urinary system medicine. The representative products Sanjin watermelon frost series and Sanjin tablets have become the first brand of similar Chinese medicines in China. Sanjinpai Trademark was recognized as "China Famous Trademark" by the State Administration for Industry and Commerce. Sanjinpai products sell well at home and abroad and enjoy a good reputation. Over the years, Sanjin has always adhered to the strategy of focusing on product management, supplemented by capital management. In management, Sanjin adheres to the "dumbbell" management mode, constantly introduces high standards from the same industry at home and abroad, and actively improves the overall quality of the enterprise; At present, the company and its pharmaceutical subsidiaries have fully passed the GMP certification of the national FSDA, and the competitive strength of enterprises has been further enhanced. At present, Sanjin has successfully entered the domestic capital market, actively responded to the call of the Guilin Municipal Party Committee and Municipal Government to "develop the western region and rebuild a new Guilin" and started a new journey. Facing the future, we will continue to adhere to the tenet of "caring for life, caring for health, saving the world with fine medicine and being loyal to science", and make continuous innovation according to the enterprise situation, so as to build Sanjin into a leading domestic and world-class research and development enterprise of Chinese patent medicines and natural medicines.